ArticleDermatology and therapy2024

Safety of Secukinumab from 1 Million Patient-Years of Exposure: Experience from Post-Marketing Setting and Clinical Trials.

Rui Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.